2021
DOI: 10.1080/0284186x.2021.1992008
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of mental disorders in patients with cancer compared to matched controls – secondary analysis of two nationally representative surveys

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0
4

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 32 publications
0
15
0
4
Order By: Relevance
“…Whilst we acknowledge that clinical interviews may produce more conservative estimates versus symptom measures, and might be onerous on research resources, the addition of clinical interviews to diagnose psychological disorders would be a valuable addition. For example, a recent study by Vehling et al 46 investigated cancer among a large well‐phenotyped sample of adults with age‐matched disease‐free controls. Participants were screened for psychological disorders and further assessed with a diagnostic clinical interview.…”
Section: Discussionmentioning
confidence: 99%
“…Whilst we acknowledge that clinical interviews may produce more conservative estimates versus symptom measures, and might be onerous on research resources, the addition of clinical interviews to diagnose psychological disorders would be a valuable addition. For example, a recent study by Vehling et al 46 investigated cancer among a large well‐phenotyped sample of adults with age‐matched disease‐free controls. Participants were screened for psychological disorders and further assessed with a diagnostic clinical interview.…”
Section: Discussionmentioning
confidence: 99%
“…In comparison with a control group, depression prevalence rates among people with cancer are at least two times higher for unipolar mood disorders (major depression: OR, 2.07; 95% CI, 1.71 to 2.51; dysthymia: OR, 2.93; 95% CI, 2.13 to 4.02). 4 Using self-report instruments with specified cutoff points (eg, Patient Health Questionnaire-9 $ 10), moderate to severe depressive symptom rates between 13% and 27% have been reported. [32][33][34][35] When diagnostic criteria for MDD are used, the prevalence is 14.3%.…”
Section: Additional Resourcesmentioning
confidence: 99%
“…AFFILIATIONS 1 The Ohio State University, Columbus, OH 2 American Society of Clinical Oncology, Alexandria, VA 3 City of Hope, Duarte, CA 4 Stanford University School of Medicine, Palo Alto, CA 5 Florida Cancer Specialists, West Palm Beach, FL 6 Inova Health Foundation, Falls Church, VA 7 Legorreta Cancer Center at Brown University and Lifespan Cancer Institute, Providence, RI 8 Michigan State University, East Lansing, MI 9 Brigham and Women's Hospital, Boston, MA 10 Dana-Farber Cancer Institute, Boston, MA 11 University of California, Los Angeles, Los Angeles, CA 12 Smith Center for Healing and the Arts, Washington, DC…”
Section: Corresponding Authormentioning
confidence: 99%
See 1 more Smart Citation
“…Untersuchungen berichten Häufigkei-ten zwischen 15 und 45 %, sowie, dass anhaltende Demoralisierung, Progredienz-und Todesängste mit einem höheren Risiko für psychische Störungen, Suizidgedanken und Schwierigkeiten in der Interaktion mit medizinischen Behandler*innen einhergehen können [3,4]. Affektive Störungen treten bei Krebspatient*innen knapp doppelt so häufig auf wie in der Allgemeinbevölkerung [5]. [15].…”
Section: Konzepte Und Häufigkeit Existenzieller Belastungenunclassified